Clinical Trials Logo

Chemokines clinical trials

View clinical trials related to Chemokines.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01339975 Completed - Kidney Diseases Clinical Trials

Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma

ChemoRenCan
Start date: June 6, 2011
Phase:
Study type: Observational

Despite novel treatment options, Renal Cell Carcinoma (RCC) has been characterized by a constant increase in its mortality and consequently requires an important involvement in translational research. The aim of this study is to evaluate the interest of CXCL4, CXCL4L1 and CXCR3 as biomarkers in localized, locally advanced or metastatic RCC. Indeed these chemokines have shown anti-angiogenic and anti-tumor properties in experimental models and may be particularly interesting for prognostic and predictive purposes.